MannKind completes follow-on

MannKind Corp. (NASDAQ:MNKD), Valencia, Calif. Business: Endocrine/Metabolic, Cancer Date completed: 2/2/12 Type: Follow-on Raised: $75 million Units: 31.3 million Price: $2.40 (unit) Shares after off...